Synovex
Stage
Other Investors | AliveAbout Synovex
Synovex is a biological research company. It specializes in developing a next-generation, non-immunosuppressive treatment for fibrosis that occurs in fibrotic diseases and debilitating cartilage destruction in rheumatoid arthritis. It is based in Medford, Massachusetts.
Missing: Synovex's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Synovex's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Synovex Patents
Synovex has filed 2 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/9/2009 | 11/26/2013 | Autoimmune diseases, Rheumatology, Inflammations, Arthritis, Rare diseases | Grant |
Application Date | 1/9/2009 |
|---|---|
Grant Date | 11/26/2013 |
Title | |
Related Topics | Autoimmune diseases, Rheumatology, Inflammations, Arthritis, Rare diseases |
Status | Grant |
Synovex Frequently Asked Questions (FAQ)
Where is Synovex's headquarters?
Synovex's headquarters is located at 200 Boston Avenue 1100, Medford.
What is Synovex's latest funding round?
Synovex's latest funding round is Other Investors.
Who are the investors of Synovex?
Investors of Synovex include MedImmune.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.